Proteus mirabilis biofilms and catheter-associated urinary tract infections

Virulence

Volumn 2, Issue 5, 2011, Pages 460-465

  Jacobsen, Sandra M ^a   Shirtliff, Mark E ^b,c  

^a University of Maryland   (United States)

^b UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Biofilms; Catheter; CAUTIs; Proteus mirabilis; Virulence

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; EDETATE SODIUM; NALIDIXIC ACID; TRICLOSAN; UREASE INHIBITOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BALLOON CATHETER; BIOFILM; CATHETER INFECTION; COLONY FORMATION; CRYSTALLIZATION; FIMBRIA; HUMAN; INDWELLING CATHETER; MOLECULAR PATHOLOGY; NONHUMAN; PROTEUS MIRABILIS; QUORUM SENSING; SCANNING ELECTRON MICROSCOPY; URINARY CATHETER; URINARY TRACT INFECTION;

PROTEUS MIRABILIS;

EID: 80053912099     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.2.5.17783     Document Type: Article

References (63)

1. Rózalski A, Sidorczyk Z, Kotelko K. Potential virulence factors of Proteus bacilli. Microbiol Mol Biol Rev 1997; 61:65- 89; PMID:9106365.
2. The genera Proteus, Providencia and Morganella. Berlin: Springer-Verlag KG 1992.
3. Warren JW, Damron D, Tenney JH, Hoopes JM, Deforge B, Muncie HL Jr. Fever, bacteremia and death as complications of bacteriuria in women with longterm urethral catheters. J Infect Dis 1987; 155:1151-1158; PMID:3572035; http://dx.doi.org/10.1093/infdis/155.6.1151.
4. Warren JW, Tenney JH, Hoopes JM, Muncie HL, Anthony WC. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis 1982; 146:719-723; PMID:6815281; http://dx.doi.org/10.1093/infdis/146.6.719.
5. Jacobsen SM, Stickler DJ, Mobley HL, Shirtliff ME. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev 2008; 21:26-59; PMID:18202436; http://dx.doi.org/10.1128/CMR.00019-07.
6. Inbakandan D, Murthy PS, Venkatesan R, Khan SA. 16S rDNA sequence analysis of culturable marine biofilm forming bacteria from a ship's hull. Biofouling 2010; 26:893-899; PMID:21038149; http://dx.doi.org/10.1080/08927014.2010.530347.
7. Reed WP, Moody MR, Newman KA, Light PD, Costerton JW. Bacterial colonization of Hemasite access devices. Surgery 1986; 99:308-317; PMID:3082026.
8. Holland SP, Pulido JS, Miller D, Ellis B, Alfonso E, Scott M, et al. Biofilm and scleral buckle-associated infections. A mechanism for persistence. Ophthalmology 1991; 98:933-938; PMID:1866148.
9. Reid G, Denstedt JD, Kang YS, Lam D, Nause C. Microbial adhesion and biofilm formation on ureteral stents in vitro and in vivo. J Urol 1992; 148:1592-1594; PMID:1433574.
10. Stickler D, Ganderton L, King J, Nettleton J, Winters C. Proteus mirabilis biofilms and the encrustation of urethral catheters. Urol Res 1993; 21:407-411; PMID:8171763; http://dx.doi.org/10.1007/BF00300077.
11. Tićac B, Ticac R, Rukavina T, Kesovija PG, Pedisic D, Maljevac B, et al. Microbial colonization of tracheoesophageal voice prostheses (Provox2) following total laryngectomy. Eur Arch Otorhinolaryngol 2010; 267:1579-1586; PMID:20432044; http://dx.doi.org/10.1007/s00405-010-1253-8.
12. McLean RJ, Lawrence JR, Korber DR, Caldwell DE. Proteus mirabilis biofilm protection against struvite crystal dissolution and its implications in struvite urolithiasis. J Urol 1991; 146:1138-142; PMID:1895441.
13. Rocha SP, Elias WP, Cianciarullo AM, Menezes MA, Nara JM, Piazza RM, et al. Aggregative adherence of uropathogenic Proteus mirabilis to cultured epithelial cells. FEMS Immunol Med Microbiol 2007; 51:319-326; PMID:17714491; http://dx.doi.org/10.1111/j.1574-695X.2007.00308.x.
14. Jones SM, Yerly J, Hu Y, Ceri H, Martinuzzi R. Structure of Proteus mirabilis biofilms grown in artificial urine and standard laboratory media. FEMS Microbiol. Lett 2007; 268:16-21; PMID:17250761; http://dx.doi.org/10.1111/j.1574-6968.2006.00587.x.
15. O'May GA, Jacobsen SM, Longwell M, Stoodley P, Mobley HL, Shirtliff ME. The high-affinity phosphate transporter Pst in Proteus mirabilis HI4320 and its importance in biofilm formation. Microbiology 2009; 155:1523-1535; PMID:19372157; http://dx.doi.org/10.1099/mic.0.026500-0.
16. Belas R, Suvanasuthi R. The ability of Proteus mirabilis to sense surfaces and regulate virulence gene expression involves FliL, a flagellar basal body protein. J Bacteriol 2005; 187:6789-803; PMID:16166542; http://dx.doi.org/10.1128/JB.187.19.6789-803.2005.
17. Stickler DJ, Zimakoff J. Complications of urinary tract infections associated with devices used for long-term bladder management. J Hosp Infect 1994; 28:177-194; PMID:7852732; http://dx.doi.org/10.1016/0195-6701(94)90101-5.
18. Hochreiter W, Knoll T, Hess B. [Pathophysiology, diagnosis and conservative therapy of non-calcium kidney calculi]. Ther Umsch 2003; 60:89-97; PMID:12649987; http://dx.doi.org/10.1024/0040-5930.60.2.89.
19. Sabbuba NA, Stickler DJ, Mahenthiralingam E, Painter DJ, Parkin J, Feneley RC. Genotyping demonstrates that the strains of Proteus mirabilis from bladder stones and catheter encrustations of patients undergoing long-term bladder catheterization are identical. J Urol 2004; 171:1925-1928; PMID:15076313; http://dx.doi.org/10.1097/01.ju.0000123062.26461.f9.
20. Stickler DJ, Feneley RC. The encrustation and blockage of long-term indwelling bladder catheters: a way forward in prevention and control. Spinal Cord 2010; 48:784-790; PMID:20368711; http://dx.doi.org/10.1038/sc.2010.32.
21. Morgan SD, Rigby D, Stickler DJ. A study of the structure of the crystalline bacterial biofilms that can encrust and block silver Foley catheters. Urol Res 2009; 37:89-93; PMID:19189089; http://dx.doi.org/10.1007/s00240-009-0176-6.
22. Stickler DJ, Morgan SD. Modulation of crystalline Proteus mirabilis biofilm development on urinary catheters. J Med Microbiol 2006; 55:489-494; PMID:16585633; http://dx.doi.org/10.1099/jmm.0.46404-0.
23. Stickler D, Young R, Jones G, Sabbuba N, Morris N. Why are Foley catheters so vulnerable to encrustation and blockage by crystalline bacterial biofilm? Urol Res 2003; 31:306-11; PMID:14574534; http://dx.doi.org/10.1007/s00240-003-0340-3.
24. Bahrani FK, Mobley HL. Proteus mirabilis MR/P fimbrial operon: genetic organization, nucleotide sequence and conditions for expression. J Bacteriol 1994; 176:3412-3419; PMID:7910820.
25. Jansen AM, Lockatell V, Johnson DE, Mobley HL. Mannose-resistant Proteus-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formation. Infect Immun 2004; 72:7294-7205; PMID:15557655; http://dx.doi.org/10.1128/IAI.72.12.7294-305.2004.
26. Liaw SJ, Lai HC, Wang WB. Modulation of swarming and virulence by fatty acids through the RsbA protein in Proteus mirabilis. Infect Immun 2004; 72:6836-6845; PMID:15557604; http://dx.doi.org/10.1128/IAI.72.12.6836-45.2004.
27. Jiang SS, Liu MC, Teng LJ, Wang WB, Hsueh PR, Liaw SJ. Proteus mirabilis pmrI, an RppA-regulated gene necessary for polymyxin B resistance, biofilm formation and urothelial cell invasion. Antimicrob Agents Chemother 2010; 54:1564-1571; PMID:20123999; http://dx.doi.org/10.1128/AAC.01219-09.
28. Izquierdo L, Abitiu N, Coderch N, Hita B, Merino S, Gavin R, et al. The inner-core lipopolysaccharide biosynthetic waaE gene: function and genetic distribution among some Enterobacteriaceae. Microbiology 2002; 148:3485-3496; PMID:12427940.
29. Liaw SJ, Lai HC, Ho SW, Luh KT, Wang WB. Role of RsmA in the regulation of swarming motility and virulence factor expression in Proteus mirabilis. J Med Microbiol 2003; 52:19-28; PMID:12488561; http://dx.doi.org/10.1099/jmm.0.05024-0.
30. Davies DG, Marques CN. A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J Bacteriol 2009; 191:1393-1403; PMID:19074399; http://dx.doi.org/10.1128/JB.01214-08.
31. Jones BV, Mahenthiralingam E, Sabbuba NA, Stickler DJ. Role of swarming in the formation of crystalline Proteus mirabilis biofilms on urinary catheters. J Med Microbiol 2005; 54:807-813; PMID:16091430; http://dx.doi.org/10.1099/jmm.0.46123-0.
32. Musher DM, Griffith DP, Yawn D, Rossen RD. Role of urease in pyelonephritis resulting from urinary tract infection with Proteus. J Infect Dis 1975; 131:177-181; PMID:234993; http://dx.doi.org/10.1093/infdis/131.2.177.
33. Mobley HL, Warren JW. Urease-positive bacteriuria and obstruction of long-term urinary catheters. J Clin Microbiol 1987; 25:2216-2217; PMID:3320089.
34. Griffith DP, Musher DM, Itin C. Urease. The primary cause of infection-induced urinary stones. Invest Urol 1976; 13:346-350; PMID:815197.
35. Jones BD, Lockatell CV, Johnson DE, Warren JW, Mobley HL. Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection. Infect Immun 1990; 58:1120-1123; PMID:2180821.
36. Johnson DE, Russell RG, Lockatell CV, Zulty JC, Warren JW, Mobley HL. Contribution of Proteus mirabilis urease to persistence, urolithiasis and acute pyelonephritis in a mouse model of ascending urinary tract infection. Infect Immun 1993; 61:2748-2754; PMID:8514376.
37. Clapham LR, McLean JC, Nickel JC, Downey J, Costerton JW. The influence of bacteria on struvite crystal habit and its importance in urinary stone formation. J Cryst Growth 1990; 104:475-484; http://dx.doi.org/10.1016/0022-0248(90)90150-J.
38. McLean RJ, Nickel JC, Cheng KJ, Costerton JW. The ecology and pathogenicity of urease-producing bacteria in the urinary tract. Crit Rev Microbiol 1988; 16:37-79; PMID:3053050; http://dx.doi.org/10.3109/10408418809104467.
39. Dumanski AJ, Hedelin H, Edin-Liljegren A, Beauchemin D, McLean RJ. Unique ability of the Proteus mirabilis capsule to enhance mineral growth in infectious urinary calculi. Infect Immun 1994; 62:2998-3003; PMID:8005688.
40. Morris NS, Stickler DJ, Winters C. Which indwelling urethral catheters resist encrustation by Proteus mirabilis biofilms? Br J Urol 1997; 80:58-63.
41. Morris NS, Stickler DJ. Encrustation of indwelling urethral catheters by Proteus mirabilis biofilms growing in human urine. J Hosp Infect 1998; 39:227-234; PMID:9699143; http://dx.doi.org/10.1016/S0195-6701(98)90262-6.
42. Sabbuba N, Hughes G, Stickler DJ. The migration of Proteus mirabilis and other urinary tract pathogens over Foley catheters. BJU Int 2002; 89:55-60; PMID:11849161; http://dx.doi.org/10.1046/j.1464-410X.2002.02560.x.
43. Chang HT, Rittmann BE, Amar D, Heim R, Ehlinger O, Lesty Y. Biofilm detachment mechanisms in a liquid-fluidized bed. Biotechnol Bioeng 1991; 38:499-506; PMID:18604808; http://dx.doi.org/10.1002/bit.260380508.
44. Chew BH, Cadieux PA, Reid G, Denstedt JD. In-vitro activity of triclosan-eluting ureteral stents against common bacterial uropathogens. J Endourol 2006; 20:949-958; PMID:17144870; http://dx.doi.org/10.1089/end.2006.20.949.
45. Jones GL, Russell AD, Caliskan Z, Stickler DJ. A strategy for the control of catheter blockage by crystalline Proteus mirabilis biofilm using the antibacterial agent triclosan. Eur Urol 2005; 48:838-845; PMID:16126323; http://dx.doi.org/10.1016/j.eururo.2005.07.004.
46. Stickler DJ, Jones GL, Russell AD. Control of encrustation and blockage of Foley catheters. Lancet 2003; 361:1435-1437; PMID:12727400; http://dx.doi.org/10.1016/S0140-6736(03)13104-2.
47. Williams GJ, Stickler DJ. Some observations on the diffusion of antimicrobial agents through the retention balloons of foley catheters. J Urol 2007; 178:697-701; PMID:17574612; http://dx.doi.org/10.1016/j.juro.2007.03.091.
48. Percival SL, Sabbuba NA, Kite P, Stickler DJ. The effect of EDTA instillations on the rate of development of encrustation and biofilms in Foley catheters. Urol Res 2009; 37:205-209; PMID:19468723; http://dx.doi.org/10.1007/s00240-009-0196-2.
49. Jones SM, Dang TT, Martinuzzi R. Use of quorum sensing antagonists to deter the formation of crystalline Proteus mirabilis biofilms. Int J Antimicrob Agents 2009; 34:360-364; PMID:19619987; http://dx.doi.org/10.1016/j.ijantimicag.2009.06.011.
50. Sosa V, Zunino P. Effect of Ibicella lutea on uropathogenic Proteus mirabilis growth, virulence and biofilm formation. J Infect Dev Ctries 2009; 3:762-770; PMID:20009277.
51. Stickler DJ, Jones GL. Reduced Susceptibility of Proteus mirabilis to triclosan. Antimicrob Agents Chemother 2008; 52:991-994; PMID:18180352; http://dx.doi.org/10.1128/AAC.01094-07.
52. Ren D, Zuo R, Wood TK. Quorum-sensing antagonist (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone influences siderophore biosynthesis in Pseudomonas putida and Pseudomonas aeruginosa. Appl Microbiol Biotechnol 2005; 66:689-695; PMID:15290134; http://dx.doi.org/10.1007/s00253-004-1691-6.
53. Beattie M, Taylor J. Silver alloy vs. uncoated urinary catheters: a systematic review of the literature. J Clin Nurs 2011; 20:2098-2108; PMID:21418360; http://dx.doi.org/10.1111/j.1365-2702.2010.03561.x.
54. Samuel U, Guggenbichler JP. Prevention of catheter- related infections: the potential of a new nanosilver impregnated catheter. Int J Antimicrob Agents 2004; 23:75-78; PMID:15037331; http://dx.doi.org/10.1016/j.ijantimicag.2003.12.004.
55. Kazmierska KA, Thompson R, Morris N, Long A, Ciach T. In vitro multicompartmental bladder model for assessing blockage of urinary catheters: effect of hydrogel coating on dynamics of Proteus mirabilis growth. Urology 2010; 76:515-520; PMID:20696356; http://dx.doi.org/10.1016/j.urology.2010.04.039.
56. Ko R, Cadieux PA, Dalsin JL, Lee BP, Elwood CN, Razvi H. First prize: Novel uropathogen-resistant coatings inspired by marine mussels. J Endourol 2008; 22:1153-1160; PMID:18484883; http://dx.doi.org/10.1089/end.2008.0049.
57. Hamill TM, Gilmore BF, Jones DS, Gorman SP. Strategies for the development of the urinary catheter. Expert Rev Med Devices 2007; 4:215-225; PMID:17359226; http://dx.doi.org/10.1586/17434440.4.2.215.
58. Stickler DJ. Bacterial biofilms and the encrustation of urethral catheters. Biofouling 1996; 9:293-305; http://dx.doi.org/10.1080/08927019609378311.
59. Chakravarti A, Gangodawila S, Long MJ, Morris NS, Blacklock AR, Stickler DJ. An electrified catheter to resist encrustation by Proteus mirabilis biofilm. J Urol 2005; 174:1129-1132; PMID:16094079; http://dx.doi.org/10.1097/01.ju.0000168618.79096.cb.
60. Stickler DJ, Jones SM, Adusei GO, Waters MG. A sensor to detect the early stages in the development of crystalline Proteus mirabilis biofilm on indwelling bladder catheters. J Clin Microbiol 2006; 44:1540-1542; PMID:16597888; http://dx.doi.org/10.1128/JCM.44.4.1540-2.2006.
61. Stickler DJ, Jones SM, Adusei GO, Waters MG, Cloete J, Mathur S, et al. A clinical assessment of the performance of a sensor to detect crystalline biofilm formation on indwelling bladder catheters. BJU Int 2006; 98:1244-1249; PMID:17026594; http://dx.doi.org/10.1111/j.1464-410X.2006.06562.x.
62. Carson L, Gorman SP, Gilmore BF. The use of lytic bacteriophages in the prevention and eradication of biofilms of Proteus mirabilis and Escherichia coli. FEMS Immunol Med Microbiol 2010; 59:447-455; PMID:20528927.
63. Jacobsen SM, Lane MC, Harro JM, Shirtliff ME, Mobley HL. The high-affinity phosphate transporter Pst is a virulence factor for Proteus mirabilis during complicated urinary tract infection. FEMS Immunol Med Microbiol 2008; 52:180-193; PMID:18194341; http://dx.doi.org/10.1111/j.1574-695X.2007.00358.x.